Your patient may need authorization to get insurance coverage for NUPLAZID® (pimavanserin).
Complete the fields below, and then submit when enrolling your patient in Acadia Connect™. (All information required unless marked optional)
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
NUPLAZID is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
Dosage and Administration
Recommended dose: 34 mg capsule taken orally once daily, without titration.
NUPLAZID is available as 34 mg capsules and 10 mg tablets.
Please read the full Prescribing Information, including Boxed WARNING.
NUPLAZID is a registered trademark of Acadia Pharmaceuticals Inc.